Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: liver

Hope for Live Births in Women with Antiphospholipid Syndrome

Lara C. Pullen, PhD  |  September 14, 2020

For women with antiphospholipid syndrome (APS), treatment with a combination of heparin and aspirin during pregnancy—rather than aspirin alone—may increase live birth rates, according to new research.

Filed under:ConditionsOther Rheumatic Conditions Tagged with:Antiphospholipid Antibody Syndrome (APS)birthHughes Syndromepregnancypregnant women

Billion Photos / shutterstock.com

How to Succeed in a Fellowship & Beyond

Bethany Marston, MD, & Jason Kolfenbach, MD  |  September 11, 2020

For most doctors, fellowship training represents the final two to three years of formal medical education, and recognition of the unique opportunities of this time period can help aspiring rheumatologists get the most out of their fellowship. Fellowship training is inherently different than residency training, with less structured time, smaller teams (often consisting of only…

Filed under:Education & TrainingProfessional Topics Tagged with:Fellows-in-Training

Measuring & Preventing Diagnostic Errors

Richard Zamore, MD, MPH  |  September 11, 2020

In a December 2019 editorial in the Journal of the American Medical Association, the implications of diagnostic error were explored through the story of two parents, both medical professionals, who sought a diagnosis for their sick child.1 Their son saw specialist after specialist and underwent repeated procedures, but for years was left without an explanation…

Filed under:Professional TopicsQuality Assurance/ImprovementSpeak Out Rheum Tagged with:DiagnosisErrorsSpeak Out Rheumatology

Every Vote Counts

Philip Seo, MD, MHS  |  September 11, 2020

It came down to the toss of a coin. David Yancey represented the Newport News district in the Virginia House of Delegates beginning in 2011. In 2017, he had a challenger. Shelly Simonds, a member of the local school board, decided to run for the privilege of representing the 94th District. The final tally: 11,608…

Filed under:OpinionRheuminationsSpeak Out Rheum Tagged with:RheumPAC

Dendritic Cells as Therapeutics: The New Frontier

Jason Liebowitz, MD, FACR  |  August 26, 2020

Cancer treatments, organ transplants and rheumatologic diseases—dendritic cells are being used throughout medicine to create innovative treatments, according to presenters of a virtual session during the European e-Congress of Rheumatology.

Filed under:Uncategorized Tagged with:dendritic cellsEULARtherapeutics

How to Create a Safe Practice & Prep for a COVID-19 Resurgence

Steven M. Harris, Esq.  |  August 12, 2020

For many months, the healthcare world has been significantly affected by the swift and per­vasive effects of SARS-CoV-2, which causes COVID-19. The virus has severely affected the delivery of patient care by all providers, including those in hospitals and emergency care settings, who grappled with the response to massive influxes of COVID-19 patients, and those…

Filed under:Legal UpdatesPractice Support Tagged with:COVID-19personal protective equipment (PPE)Safety

Figure 1A–C: Arrows denote hemophagocytic histiocytes.

Case Report: Too Many Activated Immune Cells in a 9-Month-Old Boy

Jeffrey Lo, MD  |  August 12, 2020

Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening disease of immune dysregulation characterized by unchecked inflammatory responses leading to end-organ dysfunction. Primary HLH results from inherited mutations that impair the capacity for immune regulation; secondary HLH arises from the inappropriate response to an immune stimulus, such as infection, malignancy or autoimmunity. What is less well known is…

Filed under:Conditions Tagged with:congenital disorder of glycosylation (CDG)genetic disordershemophagocytic lymphohistiocytosis (HLH)

Case Report: Diagnosing a Lupus-Flare Mimic

Nobuya Abe, MD, Yuichiro Fujieda, MD, PhD, & Tatsuya Atsumi, MD, PhD  |  August 12, 2020

The diagnosis of rheumatic diseases requires the exclusion of other systemic disorders. Infection, hematologic conditions, malignancies and some drugs may all lead to syndromes that closely mimic rheumatic diseases, which may lead to diagnostic delays. Idiopathic multicentric Castleman disease (iMCD) is a heterogeneous group of lympho­proliferative diseases (LPDs) characterized by systemic inflammatory manifestations.1,2 As with…

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:Castleman's diseaseRaynaud’s phenomenon

9 Steps to Transform Your Rheumatology Practice

Erin Arnold, MD; William Arnold, MD; Gary Crump, MD; David Sikes, MD; Drew Johnson, MS, MBA; & Timothy Harrington, MD  |  August 12, 2020

The ACR position statement on access to care proposes the goal that “… all patients have timely access to expert rheuma­tology care … .”1 The reality is that new and established rheumatology patient wait times are often prolonged, causing delays in necessary diagnosis and treatment. The 2005 and 2015 ACR Workforce studies document intractable and…

Filed under:Practice SupportSpeak Out RheumWorkforce Tagged with:Advanced Practice CliniciansAssociation of Rheumatology Professionals (ARP)Rheumatoid Arthritis Practice PerformanceSpeak Out RheumatologyTreat-to-Targetworkforce shortage

ACR Convergence 2020: Reimagining the ACR/ARP Annual Meeting

Ellen M. Gravallese, MD  |  August 5, 2020

Looking back on last year’s ACR/ARP annual meeting, I recall the energy and excitement of attendees as they participated in sessions covering the latest scientific concepts and new directions in our field. In 2019, we piloted a number of innovative ways to modernize and enhance future ACR meetings, with the promise of delivering a transformed…

Filed under:Education & TrainingPresident's Perspective Tagged with:ACR Convergence 2020

  • « Previous Page
  • 1
  • …
  • 31
  • 32
  • 33
  • 34
  • 35
  • …
  • 126
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences